PRRT2 and ovarian carcinoma: Mutations in PKCθ have been detected in lymphomas and leukemias, including 2 fusion proteins (FAM107B-PRKCQ and PTGIS-PRKCQ, respectively), with two additional fusion proteins being detected in breast and ovarian cancers [58,59].